The primary objective of this review is to determine the efficacy of screening for type 2 diabetes in reducing morbidity and mortality associated with diabetes. Specifically we want to determine whether screening is more effective than no screening i.e. diagnosis of type 2 diabetes during regular care.
The secondary objective of this study is to assess the effects of screening for type 2 diabetes on adverse events, health care consumption, quality of life, and costs.
This is a protocol.